• P-ISSN 0973-7200 E-ISSN 2454-8405
  • Follow us

Journal of Pharmaceutical Research

Article

Journal of Pharmaceutical Research

Year: 2023, Volume: 22, Issue: 3, Pages: 152-157

Original Article

Importance of Appropriate Medication Administration in Patients with Nasogastric Feeding Tube

Abstract

Solid dosage forms like modified release and enteric coated formulations are considered inappropriate for nasogastric feeding tube (NGFT) administration due to varying pharmacokinetics which could lead to inadequate therapeutic responses or toxicity. An analysis was conducted to assess the appropriateness of prescribed medicines for NGFT administration in hospital inpatients so that physicians can be sensitized to the importance of this. In this cross-sectional study conducted in a large tertiary care centre, prescription data of in-patients with nasogastric feeding tube (NGFT) were retrieved through electronic pharmacy transactions. Adult patients who were admitted in the hospital for more than one day and were dispensed a NGFT were included. The appropriateness of medicines administered through NGFT was assessed using standard published literature. Details of medicines that were categorized as inappropriate were collated and analysed. In case of inappropriate prescribing, availability of appropriate dosage forms was also determined. A total of 510 patients were found eligible for analyses. Majority of the patients were dispensed at least one inappropriate dosage form. Among the dispensed oral solid dosage forms, 16.38% were found to be inappropriate for NGFT administration. Of these, 21.41% were dispensed on same day as the NGFT, 34.67% were dispensed before the NGFT and were continued throughout the hospital stay and 43.92% were dispensed within or after 24 hours of NGFT dispensation. These findings will improve awareness among healthcare professionals about the need for appropriate administration of oral formulations in patients intubated with NGFT.

Keywords: Inappropriate Dosage Forms, Nasogastric Feeding Tube, Appropriate Dosage Forms, Modified Release Formulations

References

  1. Shargel L, Wu-Pong S, Yu A. Modified-Release Drug Products. In: Applied Biopharmaceutics & Pharmacokinetics. (Vol. 17) 2012.
  2. Sohrevardi SM, Jarahzadeh MH, Mirzaei E, Mirjalili M, Tafti AD, Heydari B. Medication Errors in Patients with Enteral Feeding Tubes in the Intensive Care Unit. Journal of Research in Pharmacy Practice. 2017;6(2):100–105. Available from: https://doi.org/10.4103/jrpp.JRPP_17_9
  3. Grissinger M. Preventing Errors When Drugs Are Given Via Enteral Feeding Tubes. Pharmacy and Therapeutics. 2013;38(10):575–581. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875244/
  4. Wasylewicz ATM, Grinsven RJBV, Bikker JMW, Korsten HHM, Egberts TCG, Kerskes CHM, et al. Clinical Decision Support System‐Assisted Pharmacy Intervention Reduces Feeding Tube–Related Medication Errors in Hospitalized Patients: A Focus on Medication Suitable for Feeding‐Tube Administration. Journal of Parenteral and Enteral Nutrition. 2021;45(3):625–632. Available from: https://doi.org/10.1002/jpen.1869
  5. Fodil M, Nghiem D, Colas M, Bourry S, Poisson-Salomon AS, Rezigue H. Assessment of clinical practices for crushing medication in geriatric units. 2017. Available from: https://doi.org/10.1007/s12603-017-0886-3
  6. Cornish P. Avoid the crush: hazards of medication administration in patients with dysphagia or a feeding tube. Canadian Medical Association Journal. 2005;172(7):871–872. Available from: https://doi.org/10.1503/cmaj.050176
  7. Schier JG, Howland MA, Hoffman RS, Nelson LS. Fatality from Administration of Labetalol and Crushed Extended-Release Nifedipine. Annals of Pharmacotherapy. 2003;37(10):1420–1423. Available from: https://doi.org/10.1345/aph.1D091
  8. Norman A, Hawkey CJ. What you need to know when you prescribe a proton pump inhibitor. Frontline Gastroenterology. 2011;2(4):199–205. Available from: https://doi.org/10.1136/flgastro-2011-100006
  9. Weaver A, Chatwell R, Churchill M, Kastanek L, Beyene J, Garceau R, et al. Improved Gastrointestinal Tolerance and Patient Preference of Enteric-Coated Sulfasalazine Versus Uncoated Sulfasalazine Tablets in Patients with Rheumatoid Arthritis. JCR: Journal of Clinical Rheumatology. 1999;5(4):193–200. Available from: https://doi.org/10.1097/00124743-199908000-00003
  10. Dézsi CA. Trimetazidine in Practice: Review of the Clinical and Experimental Evidence. American Journal of Therapeutics. 2016;23(3):871–880. Available from: https://doi.org/10.1097/MJT.0000000000000180
  11. Berkovitch M, Dafni O, Leiboviz A, Mayan H, Habut B, Segal R. Therapeutic Drug Monitoring of Theophylline in Frail Elderly Patients: Oral Compared With Nasogastric Tube Administration. Therapeutic Drug Monitoring. 2002;24(5):594–597. Available from: https://doi.org/10.1097/00007691-200210000-00003

Copyright

© 2023 Published by Krupanidhi College of Pharmacy. This is an open-access article under the CC BY-NC-ND license (https://creativecommons.org/licenses/by-nc-nd/4.0/

DON'T MISS OUT!

Subscribe now for latest articles and news.